Wave Life Sciences

Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
Fierce Biotech
Wave Life Sciences
antisense
WVE-004
clinical trials
ALS
dementia
Flag link:
'It's the right call': GSK expresses no regrets on abandoning cell therapy as oligo strategy heats up
'It's the right call': GSK expresses no regrets on abandoning cell therapy as oligo strategy heats up
Fierce Biotech
GSK
cell therapy
gene therapy
oligonucleotides
Wave Life Sciences
Flag link:
GSK Strikes $3.3B Oligonucleotide Pact with Wave Life Sciences
GSK Strikes $3.3B Oligonucleotide Pact with Wave Life Sciences
BioSpace
GSK
oligonucleotide
Wave Life Sciences
PRISM technology
Flag link:
Takeda, Wave Life Sciences revise their $230M R&D collaboration, dropping discovery work
Takeda, Wave Life Sciences revise their $230M R&D collaboration, dropping discovery work
Endpoints
Takeda
Wave Life Sciences
R&D
Flag link:
Wave culls leading Huntington's meds as shares go under after rival Roche hit by similar fate
Wave culls leading Huntington's meds as shares go under after rival Roche hit by similar fate
Fierce Biotech
Wave Life Sciences
Huntington's disease
Flag link:
Wave gets another shot at Huntington’s
Wave gets another shot at Huntington’s
EP Vantage
Wave Life Sciences
WVE-120102
Huntington's disease
Flag link:
First-quarter catalysts for the smaller players
First-quarter catalysts for the smaller players
EP Vantage
FDA
Supernus
Wave Life Sciences
Rhythm
Calithera
Matinas
Regenexbio
Flag link:
Wave Life Sciences hits tumultuous waters as ax comes crashing down on staffers
Wave Life Sciences hits tumultuous waters as ax comes crashing down on staffers
Fierce Biotech
Wave Life Sciences
layoffs
Duchenne Muscular Dystrophy
Flag link:
Clinical developments over the Christmas period
Clinical developments over the Christmas period
EP Vantage
Google Health
Axsome
Spectrum Pharmaceuticals
Wave Life Sciences
Google DeepMind
AXS-07
WVE-120102
poziotinib
Flag link:
Wave tanks again as Huntington's clinical trial data underwhelm
Wave tanks again as Huntington's clinical trial data underwhelm
Fierce Biotech
Wave Life Sciences
Huntington's disease
clinical trials
WVE-120102
Flag link:
Wave Stock Crashes After Decision to Halt Duchenne Drug Studies
Wave Stock Crashes After Decision to Halt Duchenne Drug Studies
Xconomy
Wave Life Sciences
Duchenne Muscular Dystrophy
suvodirsen
clinical trials
Flag link:
Wave faces key test in bid to challenge Sarepta in DMD
Wave faces key test in bid to challenge Sarepta in DMD
Biopharma Dive
Wave Life Sciences
Sarepta Therapeutics
Exondys 51
Duchenne Muscular Dystrophy
Flag link:
Upcoming events – Wave takes on Huntington's and Argenx goes subcutaneous
Upcoming events – Wave takes on Huntington's and Argenx goes subcutaneous
EP Vantage
Wave Life Sciences
WVE-120101
Huntington's disease
Argenx
efgartigimod
autoimmune disease
Flag link:
Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Investors Business Daily
Wave Life Sciences
suvodirsen
DMD
Merck
Keytruda
Biogen
Spinraza
Zoetis
Europe
animal health
Jazz Pharmaceuticals
JZP-258
narcolepsy
Flag link:
Wave takes a different tack from Sarepta in Duchenne
Wave takes a different tack from Sarepta in Duchenne
EP Vantage
Wave Life Sciences
Duchenne Muscular Dystrophy
suvodirsen
Sarepta Therapeutics
Flag link:
Wave down on Phase I safety data for DMD therapy
Wave down on Phase I safety data for DMD therapy
BioCentury
Wave Life Sciences
Duchenne Muscular Dystrophy
clinical trials
suvodirsen
Flag link:
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Wave Life Sciences
Sarepta Therapeutics
Novavax
ContraFect
Scynexis
earnings
Abbott Labs
Intuitive Surgical
Brainsway
Hookipa
Turning Point Therapeutics
IPOs
Flag link:
UroGen, Wave each raise $150M follow-ons
UroGen, Wave each raise $150M follow-ons
BioCentury
Urogen
Wave Life Sciences
Flag link:
Suvodirsen For Duchenne Muscular Dystrophy Selected for FDA Complex Innovative Trial Designs Pilot Program
Suvodirsen For Duchenne Muscular Dystrophy Selected for FDA Complex Innovative Trial Designs Pilot Program
CP Wire
suvodirsen
Wave Life Sciences
Duchenne Muscular Dystrophy
muscular dystrophy
Flag link:
Suvodirsen For Duchenne Muscular Dystrophy Selected for FDA Complex Innovative Trial Designs Pilot Program
suvodirsen
Wave Life Sciences
Duchenne Muscular Dystrophy
muscular dystrophy
Flag link:

Pages